Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03077178 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over

Study acronym: SARCOLD
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: 15 to 7v6
  2. Study completion date: Mar 2025 to Mar 2026v5
  3. Primary completion date changed from estimate of Mar 15, 2022 to Jan 15, 2023v4 Show 5 more changesShow less
    • Start date: Oct 15, 2017 to Nov 30, 2017
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 100 to confirmed 25
    • Study completion date: Mar 15, 2023 to Mar 2025
    • Site details revised
  4. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  5. Start date: Mar 15, 2017 to Oct 15, 2017v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Institut Bergonié
40 trials monitored
See 1 trial at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
In order to describe functional impact of surgery in elderly patients treated for lower-limb soft-tissue sarcoma, the investigators set up this project which aims to identify prognostic factors among geriatric and functional assessment.
Trial Details
NCT Number NCT03077178
Lead Sponsor Institut Bergonié
Collaborators: Ministry of Health, France
Conditions
(from sponsor)		 Soft Tissue Sarcoma Adult
Related terms Sarcoma
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov